A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Public ClinicalTrials.gov record NCT07533019. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, 24-Week, Multicenter, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Investigate Efficacy and Safety of LY4005130 in Adult Participants With Non-Segmental Vitiligo
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate how well LY4005130 is tolerated and what side effects may occur in participants with non-segmental vitiligo (NSV) when compared with placebo. The study drug will be administered intravenously (IV) (into a vein in the arm). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. The study will last approximately 48 weeks, including screening.
Study identification
- NCT ID
- NCT07533019
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 66 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 13, 2026
- Primary completion
- Apr 30, 2027
- Completion
- Aug 31, 2027
- Last update posted
- Sep 7, 2026
2026 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists | Phoenix | Arizona | 85006 | Recruiting |
| Saguaro Dermatology - Phoenix | Phoenix | Arizona | 85008 | Recruiting |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | Recruiting |
| Northridge Clinical Trials | Northridge | California | 91325 | Recruiting |
| Cura Clinical Research - Oxnard | Oxnard | California | 93030 | Recruiting |
| Cura Clinical Research - Santa Clarita - Kelly Johnson Parkway | Santa Clarita | California | 91355 | Recruiting |
| Health Clinical Research, LLC | Miami | Florida | 33189 | Recruiting |
| K2 Medical Research - Tampa | Tampa | Florida | 33634 | Recruiting |
| Advanced Medical Research, PC. | Sandy Springs | Georgia | 30328 | Recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46250 | Recruiting |
| Brigham and Women's Hospital | Boston | Massachusetts | 02115 | Recruiting |
| Revival Research Institute, LLC | Troy | Michigan | 48084 | Recruiting |
| Stracskin | Portsmouth | New Hampshire | 03801 | Recruiting |
| Equity Medical | The Bronx | New York | 10455 | Recruiting |
| Accurate Clinical Research, Inc | Humble | Texas | 77346 | Recruiting |
| Texas Dermatology and Laser Specialists - San Antonio - South New Braunfels Avenue | San Antonio | Texas | 78235 | Recruiting |
| Jordan Valley Dermatology & Research Center | South Jordan | Utah | 84095 | Recruiting |
| Clinical Research Partners, LLC | Richmond | Virginia | 23226 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07533019, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 7, 2026 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07533019 live on ClinicalTrials.gov.